Semler, E. M., Michell, D. L., Kingsley, P. J., Ramirez, M. A., Massick, C., Castleberry, M., Doran, A. C., Carr, J. J., Marnett, L., Sheng, Q., Linton, M. F., & Vickers, K. C. (2026).泭.泭Atherosclerosis,泭412, 120584.泭
Chemical modifications on RNA, calledepitranscriptomic modifications, help control how RNA works in our cells. Small RNA fragments, known astRNA-derived fragments (tDRs), can carry these modifications from their parent RNA. Some of these modified RNAs travel through the blood insidehigh-density lipoproteins (HDL), the same particles that carry good cholesterol. These HDL-associated RNAs (HDL-sRNAs) can influenceimmune responsesand may play a role inatherosclerotic cardiovascular disease (ASCVD).
In this study, we compared HDL-sRNAs from healthy people and patients with advanced ASCVD. Using methods likeLC-MS/MS,泭ARM-seq, andqPCR, we found that HDL from ASCVD patients had more RNA modifications. We identified a specific fragment,泭tDR-ArgACG, carrying a modification called1-methyladenosine (m1A), which was more common in ASCVD. When these modified RNAs enteredmacrophages, immune cells that drive inflammation in arteries, they changed gene activity, including increasingTMEM123, a protein that helps immune cells move and stick to tissues. Experiments showed that HDL carrying m1A-tDR-ArgACG boosted TMEM123 in macrophages, and blocking the m1A modification reduced this effect.
These findings suggest that HDL can deliver modified RNAs to immune cells, triggeringinflammationin atherosclerotic plaques. This reveals a new way that HDL-sRNAs may contribute to cardiovascular disease and points to potential targets for therapy.

Fig. 1CACHDL induces non-classical activation and select immune response pathway and gene expression changes in macrophages(A) Volcano plot depicting log10 p-adjusted (Q)-value versus log2 fold changes for all differentially expressed (2.0 absolute fold change) genes in BMDM’s treated with CAC+HDL or Ctr-HDL (n=3). (B) EGR1-containing gene set pathway analyses (Meta Core) enrichment, ranked by -log10(p-value) with false discovery rate (FDR) shown. (C) mRNA expression by qPCR displaying fold change from BMDMs treated with Ctr-HDL (n=9) and CAC+HDL (n=14). Statistical analysis assessed by Mann-WhitneyUtest. Data are presented as mean+s.e.m., 梯泭&梭喧;泭0.05.